2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
Approved WMORecruiting
Objective: To compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, withrespect to progression-free survival (PFS) per RECIST 1.1 as assessed by the investigator.